1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novozymes A/S
  6. News
  7. Summary
    NZYM B   DK0060336014

NOVOZYMES A/S

(NZYM B)
  Report
Delayed Quote. Delayed Nasdaq Copenhagen - 05/17 10:59:50 am
442.2 DKK   +1.89%
05/16Transactions under Novozymes' stock buyback program
GL
05/16Transactions under Novozymes' stock buyback program
GL
05/09Transactions under Novozymes' stock buyback program
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Novozymes A/S's Equity Buyback announced on February 2, 2021, has expired.

12/31/2021 EDT

The company expired its plan on December 31, 2021.


ę S&P Capital IQ 2021
All news about NOVOZYMES A/S
05/16Transactions under Novozymes' stock buyback program
GL
05/16Transactions under Novozymes' stock buyback program
GL
05/09Transactions under Novozymes' stock buyback program
GL
05/09Transactions under Novozymes' stock buyback program
GL
05/02Transactions under Novozymes' stock buyback program
GL
04/28NOVOZYMES A/S : Sowing seeds for future innovation in new plant science think tank
PU
04/27TRANSCRIPT : Novozymes A/S, Q1 2022 Earnings Call, Apr 27, 2022
CI
04/27NOVOZYMES A/S : 1st quarter report
CO
04/26Novozymes delivers strong 2022 Q1 results and raises full-year financial guidance
GL
04/26Novozymes delivers strong 2022 Q1 results and raises full-year financial guidance
GL
More news
Analyst Recommendations on NOVOZYMES A/S
More recommendations
Financials
Sales 2022 16 822 M 2 382 M 2 382 M
Net income 2022 3 166 M 448 M 448 M
Net Debt 2022 5 408 M 766 M 766 M
P/E ratio 2022 37,9x
Yield 2022 1,33%
Capitalization 120 B 17 058 M 17 058 M
EV / Sales 2022 7,48x
EV / Sales 2023 7,26x
Nbr of Employees 6 641
Free-Float 72,6%
Chart NOVOZYMES A/S
Duration : Period :
Novozymes A/S Technical Analysis Chart | NZYM B | DK0060336014 | MarketScreener
Technical analysis trends NOVOZYMES A/S
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 434,00 DKK
Average target price 476,83 DKK
Spread / Average Target 9,87%
EPS Revisions
Managers and Directors
Ester Baiget President & Chief Executive Officer
Lars Green Chief Financial Officer & Executive Vice President
J°rgen Buhl Rasmussen Chairman
Claus Crone Fuglsang Chief Scientific Officer & Executive VP
Graziela Chaluppe dos Santos Malucelli Chief Operating Officer & Executive VP